Ten-year mortality risk of patients undergoing elective PCI: long-term follow-up of the GENetic Determinants of Restenosis (GENDER) study: No increased mortality risk by restenosis, only by coronary artery disease itself

Míreanna Comhchosúla

• Matrix Metalloproteinases 2 and 3 Gene Polymorphisms and the Risk of Target Vessel Revascularization after Percutaneous Coronary Intervention: Is There Still Room for Determining Genetic Variation of MMPs for Assessment of an Increased Risk of Restenosis?
  le: Verschuren, J.J.W., et al.
  Foilsithe: (2010)
• Using genetic variation for establishing causality of cardiovascular risk factors: overcoming confounding and reverse causality
  le: Smit, R. A. J., et al.
  Foilsithe: (2014)
• Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality
  le: Trompet, Stella, et al.
  Foilsithe: (2011)
• Reply to Antipsychotics: Mortality risk factor itself?
  le: Herzig, Shoshana J., et al.
  Foilsithe: (2016)
• Systematic Testing of Literature Reported Genetic Variation Associated with Coronary Restenosis: Results of the GENDER Study
  le: Verschuren, Jeffrey J. W., et al.
  Foilsithe: (2012)